Becker's Healthcare July 2, 2024
The HHS has awarded Moderna $176 million to expand its capabilities to develop mRNA-based pandemic influenza vaccines.
The funding comes as part of the government’s Biomedical Advanced Research and Development Authority, known as BARDA, which is a program under the Administration for Strategic Preparedness and Response.
“If successfully developed, an mRNA-based licensed pandemic influenza vaccine could further improve response timelines should a new virus strain emerge and cause a pandemic, as happened with H1N1 in 2009,” the HHS said in a July 2 announcement. “Efforts under this award are intended to establish a fourth platform option to the egg-, cell-, and recombinant protein-based approaches used for production of existing, licensed influenza vaccines.”
Moderna will use the funding to secure its...
Today's Sponsors
Today's Sponsor